Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Martin Bachmann and Xuelan Liu.
Martin Bachmann
Connection Strength
1.894
Xuelan Liu
  1. AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate. Vaccines (Basel). 2021 Apr 19; 9(4).
    View in: PubMed
    Score: 0.941
  2. In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion. Allergy. 2022 01; 77(1):111-117.
    View in: PubMed
    Score: 0.242
  3. Molecular definition of severe acute respiratory syndrome coronavirus 2 receptor-binding domain mutations: Receptor affinity versus neutralization of receptor interaction. Allergy. 2022 01; 77(1):143-149.
    View in: PubMed
    Score: 0.240
  4. BNT162b2 mRNA COVID-19 vaccine induces antibodies of broader cross-reactivity than natural infection, but recognition of mutant viruses is up to 10-fold reduced. Allergy. 2021 09; 76(9):2895-2998.
    View in: PubMed
    Score: 0.237
  5. Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles. Vaccines (Basel). 2021 Apr 16; 9(4).
    View in: PubMed
    Score: 0.235
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.